Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Others	39.97M	39.50M	34.45M	17.70M		-
Others Growth	1.20%	14.67%	94.57%	-		-
Organic Chemical Raw Materials	226.86M	219.87M	263.31M	322.75M		279.56M
Organic Chemical Raw Materials Growth	3.18%	-16.50%	-18.42%	-		4.55%
Active Pharmaceutical Ingredients and Pharmaceutical Intermediates	905.51M	919.48M	946.45M	792.71M		1.07B
Active Pharmaceutical Ingredients and Pharmaceutical Intermediates Growth	-1.52%	-2.85%	19.39%	-		25.04%
Pharmaceutical Preparations	81.89M	92.47M	81.93M	85.49M		86.94M
Pharmaceutical Preparations Growth	-11.45%	12.87%	-4.17%	-		16.82%
New Energy	516.50M	783.57M	737.60M	359.21M		114.10M
New Energy Growth	-34.08%	6.23%	105.34%	-		9.00%
Total	1.77B	2.05B	2.06B	1.58B		1.55B
Total Growth	-13.83%	-0.43%	30.79%	-		17.04%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	1.45B	1.75B	1.68B	1.30B		1.23B
China Growth	-17.02%	4.48%	28.88%	-		11.87%
Overseas	316.53M	302.37M	386.41M	276.44M		322.24M
Overseas Growth	4.68%	-21.75%	39.78%	-		42.02%
Total	1.77B	2.05B	2.06B	1.58B		1.55B
Total Growth	-13.83%	-0.43%	30.79%	-		17.04%

Source: S&P Global Market Intelligence.